Chicago, IL, United States of America

Catherine Igartua

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2021-2022

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: The Innovative Contributions of Catherine Igartua

Introduction

Catherine Igartua is a prominent inventor based in Chicago, IL, known for her significant contributions to cancer diagnostics and treatment. With a total of 5 patents, she has developed groundbreaking systems and methods that enhance the understanding and classification of cancer conditions.

Latest Patents

One of her latest patents is titled "Systems and methods for multi-label cancer classification." This innovative method identifies a diagnosis of a cancer condition for a somatic tumor specimen by analyzing sequencing information derived from the specimen. The method identifies various features from the sequencing data, including RNA, DNA, RNA splicing, viral, and copy number features. It utilizes multiple classifiers to generate predictions of the cancer condition, ultimately combining these predictions to provide a comprehensive diagnosis.

Another notable patent is "Systems and methods for detecting cellular pathway dysregulation in cancer specimens." This patent discloses systems and methods that utilize RNA expression level information to determine cellular pathway disruption. This information is crucial for identifying genetic variants that may alter pathway activity, correlating these variants with disease states, and identifying effective therapeutics.

Career Highlights

Catherine has worked with leading companies in the field, including Tempus Labs, Inc. and Tempus AI, Inc. Her work has significantly impacted the landscape of cancer research and diagnostics, making her a valuable asset in the medical technology sector.

Collaborations

Throughout her career, Catherine has collaborated with notable professionals such as Joshua S. K. Bell and Nike Tsiapera Beaubier. These collaborations have further enriched her research and development efforts in cancer diagnostics.

Conclusion

Catherine Igartua's innovative work in cancer classification and pathway dysregulation detection showcases her dedication to advancing medical technology. Her contributions are paving the way for improved cancer diagnostics and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…